Bayer Reports Higher Sales and Earnings, Confirms Full-Year Outlook

Dekkers: Emerging markets were key. Emerging markets made a key contribution to Bayer’s third-quarter sales and earnings growth, chairman Marijn Dekkers says. A substantial increase in earnings at the Bayer HealthCare and Bayer CropScience subgroups was “another highlight.” But higher energy and raw material costs led to a drop in earnings at Bayer MaterialScience. Dekkers confirmed Bayer’s outlook for the year, which the company raised in April. Bayer expects to increase sales in 2011 by 5%-7%, to €36 billion-€37 billion ($50.1...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers